REQUEST A DEMO
Total
USD $0.00
Search more companies

Chemax Pharma EOOD (Химакс Фарма ЕООД) (Bulgaria)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Chemax Pharma EOOD Profile Updated: September 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Chemax Pharma EOOD (Химакс Фарма ЕООД) is based in Bulgaria. The head office is in Sofia. It operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on February 27, 2004. It currently has a total number of 134 (2024) employees. From the latest financial highlights, Chemax Pharma EOOD (Химакс Фарма ЕООД) reported a net sales revenue drop of 1.87% in 2024. There was a total growth of 7.87% in Chemax Pharma EOOD (Химакс Фарма ЕООД)’s total assets over the same period. The enterprise’s net profit margin decreased by 4.62% in 2024.

Headquarters
Ul.Goritsa 8A
Sofia; Sofia - city; Postal Code: 1618

Contact Details: Purchase the Chemax Pharma EOOD (Химакс Фарма ЕООД) report to view the information.

Basic Information
Total Employees:
Purchase the Chemax Pharma EOOD (Химакс Фарма ЕООД) report to view the information.
Registered Capital:
Purchase the Chemax Pharma EOOD (Химакс Фарма ЕООД) report to view the information.
Financial Auditors:
Purchase the Chemax Pharma EOOD (Химакс Фарма ЕООД) report to view the information.
Incorporation Date:
February 27, 2004
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Chemax Pharma EOOD (Химакс Фарма ЕООД) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-1.87%▼
Total Operating Revenue
-2.33%▼
Operating Profit
-53.1%▼
EBITDA
-47.06%▼
Net Profit/Loss for the Period
-21.07%▼
Total Assets
7.87%▲
Total Equity
9.24%▲
Operating Profit Margin
-12.8%▼
Net Profit Margin
-4.62%▼
Return on Equity (ROE)
-3.96%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?